Retrophin - 48 Year Dividend History | RTRX

Historical dividend payout and yield for Retrophin (RTRX) since 1971. The current TTM dividend payout for Retrophin (RTRX) as of July 16, 2019 is $0.00. The current dividend yield for Retrophin as of July 16, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.879B $0.164B
Retrophin is a pharmaceutical company focused on the development, acquisition and commercialization of drugs for the treatment of serious, catastrophic or rare diseases for which there are currently no viable options for patients. The Company's approved products include Chenodal?, Cholbam, and Thiola?, and its pipeline includes compounds for several catastrophic diseases, including focal segmental glomerulosclerosis, pantothenate kinase-associated neurodegeneration, infantile spasms, nephrotic syndrome and others. Retrophin, Inc. is based in San Diego.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $107.422B 12.15
Gilead Sciences (GILD) United States $86.782B 10.54
CSL (CSLLY) Australia $35.310B 0.00
Bio-Techne Corp (TECH) United States $7.974B 54.41